One of the world's largest pharmaceutical companies, Merck KGaA (ETR: MRK), has reiterated its commitment to its partnership with the Ugandan government via its non-profit subsidiary Merck Foundation, Pharmafile reported on Tuesday.
The partnership aims to bolster the country's healthcare abilities and treatment access in the region, with a particular emphasis in areas concerning cancer, cardiovascular disease, diabetes and infertility.
The 'Merck more than a mother' project was first launched in 2012.
"Raising awareness about male infertility is very important to change the culture as [it] affects women and men equally and yet women are the one who been solely blamed, discriminated and mistreated in their communities," commented Merck Foundation CEO Dr Rasha Kelej.
"The campaign will address this topic and encourage men to discuss openly their infertility and share the journey of infertility diagnosis and treatment with their wives."
Merck completes acquisition of Verona Pharma to expand cardio-pulmonary portfolio
Amgen offers Repatha through AmgenNow direct-to-patient programme
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Early, Evidence-Led Cardiovascular Care Strengthened in High-Risk MENA Regions
Corstasis and U.S. Heart and Vascular partner to advance heart failure care with ENBUMYST
Eli Lilly and Company's orforglipron outperforms oral semaglutide in Phase 3 ACHIEVE-3 trial
Merck reports positive Phase 3 results for oral PCSK9 inhibitor enlicitide
Abbott's Navitor TAVI system granted CE Mark for expanded indication
Cereno Scientific receives FDA Fast Track designation for CS1 in pulmonary arterial hypertension
FDA lifts clinical hold on Rocket Pharmaceuticals' RP-A501 Phase 2 Danon disease trial
OptiBiotix signs distribution deal with major weight management company
Novartis to present cardiovascular abstracts portfolio data at ESC Congress in Madrid
LivaNova announces commercial launch of Essenz Perfusion System in China